Is depression associated with increased oxidative stress? A systematic review and meta-analysis. (January 2015)

• Record Type: Journal Article
• Authors: Black, Catherine N.; Bot, Mariska; Scheffer, Peter G.; Cuijpers, Pim; Penninx, Brenda W.J.H.
• Is Part Of: Psychoneuroendocrinology. Volume 51(2015:Jan.)
• Page Start: 164
• Page End: 175
• Publication Date: 2015-01
• Subjects: Depression -- Major depressive disorder -- Bipolar disorder -- Oxidative stress -- 8-Hydroxy-2′-deoxyguanosine (8-OHdG) -- F2-isoprostanes; Psychoneuroendocrinology -- Periodicals; Endocrinology -- Periodicals; Neurology -- Periodicals; Psychiatry -- Periodicals; Neuropsychoendocrinologie -- Périodiques; 616.8
• DOI: 10.1016/j.psyneuen.2014.09.025
• Languages: English
• ISSNs: 0306-4530

Abstract

Highlights: A meta-analysis on oxidative stress in depression (uni- and bipolar) was performed. 10 studies (1308 subjects) on 8-OHdG in depression were included. 8 studies (2471 subjects) on F2-isoprostanes in depression were included. Overall oxidative stress was found to be increased in depression. Summary: Background: It has been suggested that depressed persons have increased oxidative stress and decreased anti-oxidant defences. 8-Hydroxy-2′-deoxyguanosine (8-OHdG) and F2-isoprostanes, measures of oxidative DNA and lipid damage respectively, are among the most reliable oxidative stress markers, but studies on their association with depression show conflicting results. This meta-analysis quantifies the association between depression and these markers and explores factors that may explain inconsistencies in the results. Methods: A systematic literature search was conducted in PubMed, EMBASE and PsycINFO. Studies assessing the association of 8-OHdG or F2-isoprostanes with elevated depressive symptoms, major depressive disorder (MDD) or bipolar disorder (BD) were pooled in two random-effect models. Results: The pooled effect size (Hedges' g ) for the association of depression with oxidative stress was 0.31 ( p = 0.01, I 2 = 75%) for 8-OHdG (10 studies, 1308 subjects) and 0.48 ( p = 0.001, I 2 = 73%) for F2-isoprostanes (8 studies, 2471 subjects), indicating that both markers are increased in depression. There was no indication of publication bias for either marker. The F2-isoprostane results did not differ by type of depression, biological specimen, laboratory method or quality, however subgroup analyses in the 8-OHdG studies showed significantly stronger associations in plasma/serum vs. urine samples ( p < 0.01), in measurements performed with immuno-assay vs. chromatography–mass spectrometry ( p < 0.01) and weaker associations in high quality studies vs. low ( p = 0.02). Conclusion: This meta-analysis finds that oxidative stress, as measured by 8-OHdG and F2-isoprostanes, is increased in depression. Larger-scale studies are needed to extend the evidence on oxidative stress in depression, and examine the potential impact of treatment.